Dow Jones

38,686.32

0.00%

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

CLNN

Clene (CLNN)

Clene Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CLNN

1 2 3 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
01/05/2024	07:30	GlobeNewswire Inc.	IBN Announces From Lab to Launch Podcast Featuring Clene Inc. CEO Rob Etherington	NASDAQ:CLNN	Clene Inc
19/03/2024	07:30	GlobeNewswire Inc.	IBN Announces First in Human Podcast Featuring Clene Inc. CEO Rob Etherington	NASDAQ:CLNN	Clene Inc
29/02/2024	07:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CLNN	Clene Inc
14/02/2024	16:21	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:CLNN	Clene Inc
29/11/2023	15:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CLNN	Clene Inc
07/11/2023	07:05	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:CLNN	Clene Inc
07/11/2023	06:47	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CLNN	Clene Inc
06/10/2023	15:11	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:CLNN	Clene Inc
29/09/2023	15:17	Edgar (US Regulatory)	Form S-3/A - Registration statement under Securities Act of 1933: [Amend]	NASDAQ:CLNN	Clene Inc
22/09/2023	15:16	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:CLNN	Clene Inc
19/09/2023	15:11	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:CLNN	Clene Inc
28/06/2023	15:31	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:CLNN	Clene Inc
28/06/2023	15:30	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:CLNN	Clene Inc
27/06/2023	13:14	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CLNN	Clene Inc
20/06/2023	14:04	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:CLNN	Clene Inc
16/06/2023	16:10	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:CLNN	Clene Inc
16/06/2023	16:07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CLNN	Clene Inc
16/06/2023	16:05	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:CLNN	Clene Inc
16/06/2023	07:02	Edgar (US Regulatory)	Registration of Additional Securities (up to 20%) (s-3mef)	NASDAQ:CLNN	Clene Inc
19/05/2023	15:03	Edgar (US Regulatory)	Specialized Disclosure Report (sd)	NASDAQ:CLNN	Clene Inc
12/05/2023	15:25	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:CLNN	Clene Inc
28/03/2023	15:11	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:CLNN	Clene Inc
28/03/2023	15:08	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:CLNN	Clene Inc
17/03/2023	16:15	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:CLNN	Clene Inc
02/02/2023	05:06	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:CLNN	Clene Inc
08/11/2022	09:10	TipRanks	Analysts’ Opinions Are Mixed on These Healthcare Stocks: Adaptimmune Therapeutics (ADAP) and Clene (CLNN)	NASDAQ:CLNN	Clene Inc
03/10/2022	08:14	TipRanks	Clene Nosedives After Lead Candidate Fails ALS Trial	NASDAQ:CLNN	Clene Inc
21/09/2022	09:25	TipRanks	Clene (CLNN) Gets a Buy from H.C. Wainwright	NASDAQ:CLNN	Clene Inc
17/08/2022	15:00	AllPennyStocks.com	Oppenheimer Price Target Adjusted To Over +300% Of Current Price	NASDAQ:CLNN	Clene Inc
18/07/2022	05:17	TipRanks	Clene (CLNN) Has a New Rating from H.C. Wainwright	NASDAQ:CLNN	Clene Inc